Bioethics News

California’s $3-Billion Bet on Stem Cells Faces Final Test

Major investment in regenerative medicine enters its last stage — and the money might run out before treatments are ready

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.